Citrome, Leslie <br/><br/>
Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia?  [electronic resource] 

 -  Evidence-based mental health  05 2016 
 - e6 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1468-960X 
<br/><br/><label>Standard No.: </label>10.1136/eb-2015-102143  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--therapeutic use<br/>Dopamine--therapeutic use<br/>Dopamine Agonists--therapeutic use<br/>Humans<br/>Schizophrenia--drug therapy